PATENT CLAIM ANALYSIS

Application Number: 16315710
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-05
Patent Classification: ["514", "235200"]

Abstract:
The present invention relates to a compound of the formula: where n, R and R are those defined herein. The present invention also relates to use of a compound of Formula 1 in treating a clinical condition associated with fibrotic disorder.

Claim (Index 9):
The compound of  claim 1  of formula (Ib) wherein\n X 1  is \u2014NR 4 R 5 , \u2014NHC(O)R 6 , \u2014NHSO 2 NR 4 R 5  or \u2014NHSO 2 R 6 ; \n R 3  and R 3\u2032  are each independently hydrogen or methyl; \n when X 1  is \u2014NR 4 R 5 , R 4  and R 5  together with the nitrogen atom to which they are attached to form a piperazine ring, wherein the piperazine ring substituted with R 7 , wherein R 7  is \u2014SO 2 R 12  or \u2014SO 2 NR 8 R 9 , wherein\n R 8  and R 9  are alkyl; and \n R 12  is phenyl substituted with halogen or \u2014O-haloalkyl, \n \n when X 1  is \u2014NHC(O) 6 , R 6  is pyrrolidinyl, \n when X 1  is \u2014NHSO 2 NR 4 R 6 , wherein R 5  and R 5  are alkyl, and \n when X 1  is \u2014NHSO 2 R 6 , R 6  is phenyl substituted with one or more of \u2014O-alkyl, halogen, haloalkyl, \u2014O-haloalkyl, \u2014O-(5-(trifluoromethyl)pyridin-2-yl), \u2014O-phenyl or cyano.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 99.0
- Lexical Diversity: 1.36364
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15736450', '14000829', '15315461', '15738900', '10516681']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7267987553598528
- 35 USC 102 Novelty (BERT): 0.5041767385720124
- Combined Prediction Score: 0.7045365536810687
- Mean Citation Score: 234.662008
- Max Citation Score: 248.7203
- Similarity Product: 192.9202032649756

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test